Skip to main content
. 2022 Sep 30;27(3):257–264. doi: 10.3746/pnf.2022.27.3.257

Table 1.

Characteristics of included trials

Reference Number of subject Duration of intervention Subject (country) Intervention Comparison
Thazhath et al. (2016) 28 5 wk T2DM on diet control (Australian) Resveratrol capsules (n=14) Placebo (n=14)
Yang et al. (2017) 160 12 wk Prediabetes or early untreated diabetes (Chinese) Purified anthocyanins (n=80) Placebo (n=80)
Zare Javid et al. (2017) 43 4 wk DM (Iranian) Resveratrol capsules (n=21) Placebo (n=22)
Khodabandehloo et al. (2018) 45 8 wk T2DM (Iranian) Resveratrol capsules (n=25) Placebo (n=20)
Abdollahi et al. (2019) 71 8 wk T2DM (Iranian) Resveratrol capsules (n=35) Placebo (n=36)
Mollace et al. (2019) 60 30 d T2DM (Italian) Bergamot polyphenolic fraction (n=40) Placebo (n=20)
Stote et al. (2020) 52 8 wk T2DM (American men) Freeze-dried blueberries (n=26) Placebo (n=26)
Yang et al. (2021) 138 12 wk Prediabetes or newly diagnosed diabetes (Chinese) Anthocyanins capsules from natural bilberry and blackcurrant (n=76) Placebo (n=62)
Nikbakht et al. (2021) 26 4 wk T2DM, T2DM-at-risk, healthy (Australian) Anthocyanins capsules from natural bilberry and blackcurrant (n=26)

T2DM, type 2 diabetes mellitus.